2025 annual financial data
Radiopharm Theranostics 2025 Operating margin
Radiopharm Theranostics 2025 operating margin with verified reported values.
Direct answer
Operating margin was -1,050.63%.
Operating income was -38,173,865 AUD and net income was -38,342,457 AUD.
Operating cash flow was -36,645,477 AUD.
Get free Radiopharm Theranostics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,633,422 AUD
- Operating income
- -38,173,865 AUD
- Net income
- -38,342,457 AUD
- Operating cash flow
- -36,645,477 AUD